oncolytic adenovirus expressing GMCSF
exBOND 2.1
Phase 2 mab terminated
Quick answer
oncolytic adenovirus expressing GMCSF for Bladder Cancer is a Phase 2 program (mab) at CG Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CG Oncology
- Indication
- Bladder Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated